Zepp Health (NYSE:ZEPP) PT Set at $53.01 by Fundamental Research

Zepp Health (NYSE:ZEPP) received a $53.01 price objective from Fundamental Research in a research report issued on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock.

Separately, Wall Street Zen cut shares of Zepp Health from a “hold” rating to a “sell” rating in a research note on Sunday, July 26th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $53.01.

Zepp Health Price Performance

Zepp Health stock traded down $0.04 during midday trading on Tuesday, hitting $5.16. The company’s stock had a trading volume of 11,653 shares, compared to its average volume of 111,247. The company has a quick ratio of 0.67, a current ratio of 0.88 and a debt-to-equity ratio of 0.21. The stock’s 50-day moving average price is $5.09 and its 200-day moving average price is $12.29. Zepp Health has a 12 month low of $3.85 and a 12 month high of $61.85. The company has a market capitalization of $75.68 million, a PE ratio of -2.05 and a beta of 1.86.

Insider Activity at Zepp Health

In other news, CFO Cheng Deng sold 9,836 shares of the company’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $4.61, for a total transaction of $45,343.96. Following the completion of the sale, the chief financial officer directly owned 114,539 shares of the company’s stock, valued at $528,024.79. This represents a 7.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Zepp Health

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio purchased a new position in shares of Zepp Health in the third quarter worth approximately $43,000. Osaic Holdings Inc. boosted its stake in Zepp Health by 239.5% in the 4th quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock worth $223,000 after purchasing an additional 5,845 shares during the period. Dimensional Fund Advisors LP acquired a new position in Zepp Health in the 4th quarter worth approximately $241,000. Capstone Capital Management Ltd purchased a new position in Zepp Health during the 4th quarter worth approximately $298,000. Finally, Mangrove Partners IM LLC purchased a new position in Zepp Health during the 4th quarter worth approximately $387,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.